title: Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.
abstract: Capsule formation is believed to have a significant role in bacterial virulence. To examine the possible involvement of capsular polysaccharide (CP) from Staphylococcus aureus in the pathological mechanisms associated with staphylococcal infections, we investigated the influence of respiratory activity on type 5 CP production by S. aureus grown in the presence of various concentrations of dissolved oxygen or nitrate. The effects of several metabolic inhibitors (arsenite, cyanide, azide, trimethylamine N-oxide, 2-heptyl-4-hydroxyquinoline N-oxide, and 2,4-dinitrophenol) were also tested. The metabolism of the bacteria was estimated by measuring their reductive capacity and by monitoring the pH and concentrations of fermentation products. Type 5 CP was always produced by S. aureus during the exponential phase of growth under all culture conditions tested. In contrast, post-exponential-phase CP production appeared to be strictly dependent on the respiratory activity. Since post-exponential-phase CP production contributes at least two-thirds of the total CP obtained, the influence of S. aureus respiration on CP production might be of some importance in the process of infection.
authors.affiliation: Département d'Ecologie, Insitut Pasteur, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Dassy
authors.forename: J M
authors.initials: JM
authors.lastname: Fournier
mesh_terms: D000963:Antimetabolites / Q000494:pharmacology; D016667:Bacterial Capsules; D006801:Humans; D006863:Hydrogen-Ion Concentration; D017942:Nitric Acid / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D011135:Polysaccharides, Bacterial / Q000096:biosynthesis*; D013203:Staphylococcal Infections / Q000209:etiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000378:metabolism* / Q000472:pathogenicity; D014774:Virulence / Q000502:physiology
chemical_list: D000963:Antimetabolites; D011135:Polysaccharides, Bacterial; C054106:capsular polysaccharide, type 5, Staphylococcus aureus; D017942:Nitric Acid